Navigation Links
Experts converge at Arizona State University for first preventive cancer vaccine conference
Date:12/10/2010

World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.

Despite 40 years since the "War on Cancer" was declared, cancer remains a leading cause of death in the world. Cancer is the second leading cause of death in the United States, with an estimated 1.5 million cases of cancer diagnosed in 2010. According to the American Cancer Society, more than 569,000 Americans are expected to die from the disease in this year.

"Cancer's course is often long and devastating and, despite advances in diagnosis and treatment, far too many will succumb to cancer," said Stephen Albert Johnston, director of the Biodesign Institute at ASU's Center for Innovations in Medicine and host of the conference. "We are trying to stimulate the cancer community to fundamentally rethink how we approach this problem. The goal of the meeting is to have scientists and clinicians consider how we could parlay all our advances in technologies and basic knowledge into making a vaccine that would be given to all adults to prevent the occurrence of cancer."

Johnston was one of the recipients of the prestigious Innovator Awards from the Department of Defense's Breast Cancer Research Program. His group has been using the 5-year, $7.5 million award to advance the technology needed for a preventative breast cancer vaccine.

Johnston notes that the most successful medical intervention in history to save lives has been the development of vaccines against infectious disease. Vaccines against pathogens that cause cancer, such as the human papilloma virus that causes cervical cancer, have been successful. But viral caused cancers are only a small fraction of all cancers. "Developing a cancer vaccine against all cancers especially those not caused by pathogens would be the perfect solution, not only in eliminating cancer mortality, but also potentially some of the costs of diagnosis, treatment and personal suffering."

The conference will be the first forum to gather the scientific community in a cooperative effort to eradicate cancer through vaccines. Conference participants will have the opportunity to provide input to address current translational challenges and regulatory hurdles to bring the first prophylactic cancer vaccine to human clinical trials.

The conference sessions will be held at the Old Main building at 400 E. Tyler Mall on the Arizona State University Tempe Campus. The event is sponsored by the Biodesign Institute at ASU, Sigma Life Science and CPC Scientific. For more registration, hotel and travel information, visit www.cancereradication.com.


'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
Source:Eurekalert

Related biology news :

1. Experts will meet to discuss how diet affects behavioral development of children
2. Pharmaceutical sciences experts present cutting-edge research at international meeting
3. Seafood stewardship questionable: UBC-Scripps experts
4. 1,500 worldwide experts debate the latest advances in breast pathologies treatments in Valencia
5. Experts identify biological control to contain fungus killer in Kenyas maize supply
6. Beyond polar bears? Experts look for a new vision of climate change to combat skepticism
7. Meeting of ICES/CIEM experts in Bilbao on state of demersal fish populations
8. NYU Cancer Institute experts present at American Society of Clinical Oncology annual meeting
9. Texas Childrens Hospital vaccine experts present 4 studies
10. Eating disorders, obesity and communications experts tackle weighty matters
11. Top microbiology experts meet in Edinburgh at SGM Spring Conference 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... --> --> Fourth quarter 2015:   ... compared with fourth quarter of 2014. Gross margin was 46% ... Earnings per share increased to SEK 6.39 (loss: 0.49). ... , --> --> January ... (233.6), up 1,142% compared with 2014. Gross margin was 43% ...
(Date:2/3/2016)... Calif. , Feb. 3, 2016 Vigilant ... Police Department in Missouri ... license plate reader (LPR) data from Vigilant Solutions. ... hit-and-run case in which the victim was walking out of a convenience ... parking space next to his vehicle, striking his vehicle ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... February 11, 2016 , ... Global ... treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols and ... from around the world. , The new GSCG clinic is headed by ...
(Date:2/10/2016)... , Feb. 10, 2016  The Maryland House ... , has announced that University of Maryland School of ... MBA and University of Maryland Medical System President and ... the "Speaker,s Medallion," the highest honor given to the ... Delegates. Dean Reece and Mr. Chrencik ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... that it has joined the Human Vaccines Project, a public-private partnership to ... cancer. , The Human Vaccines Project brings together leading pharmaceutical and ...
(Date:2/10/2016)...  Matchbook, Inc., a company specializing in procurement ... announced today the appointment of Jim Shuman ... nearly 25 years of experience in supply chain, ... two decades in executive level roles as the ... and, most recently headed global logistics and procurement ...
Breaking Biology Technology: